Skip to content
Search

Latest Stories

Can dairy disrupt your sleep? Study links certain foods to nightmares

According to the findings, 40.2% of respondents said their eating habits had an impact on their sleep

Can dairy disrupt your sleep

The authors acknowledged potential limitations in their findings

iStock

Key points

  • 40% of participants in a new study said food affects their sleep
  • Dairy and sweets were linked to worse sleep and more disturbing dreams
  • Fruit, herbal tea and vegetables were associated with better sleep quality
  • Authors suggest that lactose intolerance may play a role in dream disturbance

A recent study has explored how food may influence sleep and dreaming, with some participants reporting that certain items — particularly dairy and sweets — disrupted their rest and contributed to nightmares.

Study looked at food, sleep and dreams

The research, published in the journal Frontiers in Psychology on Monday, analysed responses from 1,082 college-aged participants who completed online surveys between January and April 2023. The survey asked about over a dozen food categories, including dairy, meat, fruit, desserts, and spicy foods.


According to the findings, 40.2% of respondents said their eating habits had an impact on their sleep. About 25% stated that at least one food group made their sleep worse, while 20% said that some foods improved it.

Among the foods most commonly associated with disrupted sleep were dairy products (milk, yoghurt, cheese), desserts and sweets, and spicy dishes. On the other hand, fruit, vegetables, and herbal tea were most often credited with improving sleep quality.

Dairy and sweets linked to disturbing dreams

When asked about the effect of food on dreaming, 5.5% of participants said they noticed a link. Of those, 31% said desserts and sweets triggered nightmares, while 22% blamed dairy.

The study’s authors noted that while the data is based on self-reported experiences and may lack scientific proof, previous research does support the possibility that food can influence sleep patterns.

They added that the connection between dairy and negative dream experiences could be due to gastrointestinal symptoms in people with lactose intolerance, such as bloating or cramps, which may disrupt sleep and affect dream quality.

Limitations of the study

The authors acknowledged potential limitations in their findings. All participants were university students enrolled in psychology courses, meaning they may have had prior knowledge of related topics that could have influenced their responses.

Despite this, the research adds to a growing body of evidence suggesting that what we eat may affect not only how well we sleep, but how we dream.

More For You

heatwave

The Met Office and UK Health Security Agency (UKHSA) have issued amber heat-health alerts

Getty Images

Doctors warn of hidden signs of heat stroke as UK issues amber alerts

Key points

  • Amber heat-health alerts issued as temperatures approach 35°C in parts of the UK.
  • Early signs of heat stroke include confusion, slurred speech, and dizziness.
  • Heat exhaustion can develop into heat stroke if not treated within 30 minutes.
  • At-risk groups include the elderly, young children, and those with health conditions.
  • NHS and health experts urge people to stay hydrated, cool, and avoid midday sun.

Medical experts are urging the public to remain alert for the early signs of heat stroke, as temperatures across parts of England are expected to reach up to 35°C. The Met Office and UK Health Security Agency (UKHSA) have issued amber heat-health alerts, warning that extreme heat can have serious health impacts. Doctors stress that symptoms can begin subtly, making early intervention crucial.

Heat alerts across multiple regions

Amber-level warnings are in effect for the West Midlands, East Midlands, Yorkshire and the Humber, South East, South West, London, and the East of England.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
Weight Loss Drug

Health officials expect the rollout to benefit around 220,000 adults over the next 3 years

iStock

NHS GPs to prescribe Mounjaro in nationwide obesity treatment plan

Key points

  • NHS GPs in England can now prescribe Mounjaro (tirzepatide) for weight loss
  • The programme aims to support 220,000 people over three years
  • Eligible patients must have a BMI over 40 and at least four obesity-related health issues
  • GP leaders raise concerns over increased workload
  • Pharmacists urge a broader weight management approach

NHS expands obesity treatment with Mounjaro

The NHS in England is set to begin prescribing Mounjaro, a weight loss injection, through GP surgeries starting Monday. The move marks the first time family doctors will be authorised to directly prescribe the anti-obesity drug tirzepatide as part of a wider national health initiative.

Health officials expect the rollout to benefit around 220,000 adults over the next three years. The drug will be made available to those with a body mass index (BMI) above 40 who also suffer from at least four other obesity-related conditions, such as type 2 diabetes, high blood pressure, or sleep apnoea.

Keep ReadingShow less
UK heatwave deaths

Around 85% of the projected deaths are likely to involve people over the age of 65

iStock

Scientists warn current UK heatwave may cause nearly 600 early deaths

Almost 600 premature deaths are expected to occur during the ongoing heatwave affecting England and Wales, according to a new rapid analysis by leading scientists. The majority of fatalities are projected among older adults, with London and the West Midlands likely to be the worst-affected areas.

Climate change driving deadly temperatures

Researchers say the extreme temperatures, which have reached 32°C in parts of south-east England, would have been nearly impossible without the influence of human-caused climate change. Pollution from burning fossil fuels has raised the likelihood of such heatwaves by around 100 times, experts say.

Keep ReadingShow less
Amycretin

'The Lancet' and presentations at the American Diabetes Association’s 2025

iStock

New weight-loss pill Amycretin shows greater impact than jabs, study finds

A new weight-loss drug, amycretin, has delivered the most significant results yet for appetite-suppressing GLP-1 medications, according to two newly published studies in The Lancet and presentations at the American Diabetes Association’s 2025 Scientific Sessions in Chicago.

Record weight loss from Amycretin injections

Researchers found that participants receiving high-dose weekly injections of amycretin lost 24.3 per cent of their body weight over 36 weeks. This outcome surpasses the results seen in longer trials involving other GLP-1 drugs such as tirzepatide (sold as Mounjaro), which previously led the field with an average weight loss of 20 per cent over 72 weeks.

Keep ReadingShow less